Latest Acquisitions News

Pacific Resources (ASX: PXR) has advanced its acquisition of the Snowstorm Gold Project in Victoria’s Eastern Goldfields by paying $160,000 to acquire a 50% stake in Mines of Stirling, the project’s owner. Completion of the acquisition, including full ownership, is expected by mid-July.

4DMedical launches the CLEAR clinical evidence program to accelerate adoption of its CT:VQ™ imaging technology in the US acute pulmonary embolism market, aiming to expand its addressable market to US$3 billion.

Tasmea Limited is set to acquire Maxim Group for up to A$254 million, bolstering its presence in Victoria and accelerating exposure to high-growth sectors like Data Centres, BESS, and Infrastructure. The deal promises immediate EPS accretion of around 31% and positions Tasmea as one of the largest electrical contractors on the ASX.

Collins Foods has expanded its German presence by acquiring eight KFC restaurants in Bavaria, increasing its portfolio by 50% and strengthening its growth strategy in Europe.

Evion Group has appointed former Australian Ambassador to the US, Arthur Sinodinos, as Strategic Advisor to accelerate its US critical minerals strategy following its acquisition of the CARP Fluorspar Project in Nevada.

SRG Global has locked in $1.85 billion in contracts across multiple sectors and upgraded its FY26 EBITDA guidance to the top end of $168 million, while initiating FY27 guidance between $190 million and $200 million, surpassing market expectations.

Forrestania Resources has updated its MacPhersons deposit resource to 73,800 ounces, pushing its global JORC-compliant gold resource past the one million ounce mark. This milestone underscores the company’s growing footprint in Western Australia’s Eastern Goldfields.

Intelligent Monitoring Group (ASX:IMB) has finalized its A$37 million purchase of Wormald NZ and Red Wolf, expanding its New Zealand footprint and projecting a 20.9% accretion in earnings per share.

ReadyTech Holdings has dismissed an unsolicited acquisition proposal valuing the company at $2.00 per share, calling it undervalued and unworkable. The offer includes a parallel off-market bid at $1.75 per share with a 50.1% minimum acceptance condition.

Little Green Pharma (ASX:LGP) has completed its merger with Cannatrek, creating a dominant player in Australia and Europe’s medicinal cannabis market with a majority stake held by former Cannatrek shareholders.

4DMedical has leapfrogged into the European lung health market by acquiring Austrian AI imaging firm contextflow, gaining immediate commercial presence and a CE-marked lung cancer screening solution.

ARC Funds Limited has secured $600,000 through a share placement priced at a 33% premium to its last traded price, aiming to strengthen its working capital and support growth initiatives.